Arcadia Biosciences Insider Trades
NASDAQ: RKDAEnergyOil & Gas ProductionUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Arcadia Biosciences insider activity
No Arcadia Biosciences insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Kawakami Mark (Chief Financial Officer) buying 700 shares at $2.49 on Feb 3, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RKDA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RKDA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 3, 2025 | Schaefer Thomas J.Chief Executive Officer | Buy | 700 | $1.74K | Form 4 |
| Feb 3, 2025 | Kawakami MarkChief Financial Officer | Buy | 700 | $1.74K | Form 4 |
| Aug 1, 2024 | Kawakami MarkChief Financial Officer | Buy | 700 | $1.44K | Form 4 |
| Aug 1, 2024 | Schaefer Thomas J.Chief Executive Officer | Buy | 700 | $1.44K | Form 4 |
| Feb 1, 2024 | Schaefer Thomas J.Chief Financial Officer | Buy | 700 | $1.44K | Form 4 |
| Aug 4, 2023 | Schaefer Thomas J.Chief Financial Officer | Buy | 649 | $2.38K | Form 4 |
| May 30, 2023 | Jacot Stanley JrChief Executive Officer | Buy | 5,000 | $21.55K | Form 4 |
| Feb 1, 2023 | Schaefer Thomas J.Chief Financial Officer | Buy | 700 | $161 | Form 4 |
| Aug 1, 2022 | Haley PamelaChief Financial Officer | Buy | 700 | $490 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4